Asthma
Conditions
Keywords
Asthma, Asthma in Children
Brief summary
To assess asthma control in Russian patients according to the new criteria provided in the international guidelines and identify pharmacological approaches that provide a higher level of overall asthma control
Interventions
None listed
Sponsors
AstraZeneca
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Male and female patients over 18 years of age * Patients with asthma diagnosed in accordance with the Global Initiative for Asthma (GINA \[xv\]) within 6 months before inclusion into the study. Patients with no changes in their treatment within 2 months before inclusion into the study * Patients who signed their informed consents to collection and further processing of data on their disease course
Exclusion criteria
* Asthma patients with an exacerbation at the moment of inclusion. * Patients on β-blockers. * Patients with COPD, mucoviscidosis or bronchiectasis, Severe heart failure (NYHA functional class III-IV), Renal insufficiency, Cancer, Previous stroke. * Pregnant women. * Patients following a major surgery, Hepatic insufficiency.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess asthma control in Russian patients acc. to the new criteria in the international guidelines (Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice) and identify pharmacological approaches provided a higher level of control | 1 visit for 3 month |
Secondary
| Measure | Time frame |
|---|---|
| To determine the main demographic, clinical and pharmacoepidemiological characteristics of low-control patients. | 1 visit for 3 month |
| To assess comparative value of the Asthma Control Questionnaire (ACT) and Asthma Control Questionnaire (ACQ) with regard to their use in clinical practice in Russia | 1 visit for 3 month |
Countries
Russia
Outcome results
None listed